Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

@article{Bright2005IncidenceOA,
  title={Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern},
  author={R. Bright and M. Medina and X. Xu and G. Perez-Oronoz and A. Klimov},
  journal={The Lancet},
  year={2005},
  volume={366},
  pages={1175-1181}
}
  • R. Bright, M. Medina, +2 authors A. Klimov
  • Published 2005
  • Medicine
  • The Lancet
  • BACKGROUND Adamantanes have been used to treat influenza A virus infections for many years. Studies have shown a low incidence of resistance to these drugs among circulating influenza viruses; however, their use is rising worldwide and drug resistance has been reported among influenza A (H5N1) viruses isolated from poultry and human beings in Asia. We sought to assess adamantane resistance among influenza A viruses isolated during the past decade from countries participating in WHO's global… CONTINUE READING

    Topics from this paper.

    Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
    • 466
    • PDF
    Adamantane-Resistant Influenza A Viruses in the World (1902–2013): Frequency and Distribution of M2 Gene Mutations
    • 133
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 32 REFERENCES
    H5N1 influenza: a protean pandemic threat.
    • 397
    • PDF